News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
580,258 Results
Type
Article (46078)
Company Profile (89)
Press Release (534091)
Multimedia
Podcasts (46)
Webinars (11)
Section
Business (160198)
Career Advice (2495)
Deals (28906)
Drug Delivery (100)
Drug Development (75115)
Employer Resources (149)
FDA (14076)
Job Trends (12830)
News (283953)
Policy (28185)
Tag
Academia (2783)
Academic (1)
Accelerated approval (5)
Adcomms (26)
Allergies (80)
Alliances (41888)
ALS (92)
Alzheimer's disease (1425)
Antibody-drug conjugate (ADC) (131)
Approvals (14070)
Artificial intelligence (252)
Autoimmune disease (22)
Automation (16)
Bankruptcy (325)
Best Places to Work (10411)
BIOSECURE Act (19)
Biosimilars (90)
Biotechnology (67)
Bladder cancer (79)
Brain cancer (29)
Breast cancer (273)
Cancer (2205)
Cardiovascular disease (185)
Career advice (2102)
Career pathing (34)
CAR-T (148)
Cell therapy (403)
Cervical cancer (18)
Clinical research (61034)
Collaboration (760)
Compensation (281)
Complete response letters (22)
COVID-19 (2601)
CRISPR (42)
C-suite (251)
Cystic fibrosis (88)
Data (2138)
Decentralized trials (2)
Denatured (8)
Depression (50)
Diabetes (258)
Diagnostics (5969)
Digital health (16)
Diversity (6)
Diversity, equity & inclusion (38)
Drug discovery (117)
Drug pricing (94)
Drug shortages (25)
Duchenne muscular dystrophy (92)
Earnings (56141)
Editorial (39)
Employer branding (22)
Employer resources (136)
Events (80101)
Executive appointments (733)
FDA (15239)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (698)
Gene editing (103)
Generative AI (21)
Gene therapy (311)
GLP-1 (700)
Government (4372)
Grass and pollen (5)
Guidances (56)
Healthcare (17061)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (126)
Indications (27)
Infectious disease (2745)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (91)
Interviews (526)
IPO (13053)
IRA (42)
Job creations (2799)
Job search strategy (1726)
Kidney cancer (11)
Labor market (21)
Layoffs (428)
Leadership (24)
Legal (6076)
Liver cancer (75)
Lung cancer (323)
Lymphoma (147)
Machine learning (7)
Management (52)
Manufacturing (274)
MASH (73)
Medical device (11253)
Medtech (11257)
Mergers & acquisitions (16338)
Metabolic disorders (668)
Multiple sclerosis (78)
NASH (23)
Neurodegenerative disease (101)
Neuropsychiatric disorders (31)
Neuroscience (1975)
NextGen: Class of 2025 (5934)
Non-profit (4406)
Now hiring (31)
Obesity (345)
Opinion (228)
Ovarian cancer (73)
Pain (86)
Pancreatic cancer (84)
Parkinson's disease (147)
Partnered (20)
Patents (221)
Patient recruitment (106)
Peanut (42)
People (53140)
Pharmaceutical (26)
Pharmacy benefit managers (10)
Phase I (18899)
Phase II (26863)
Phase III (20305)
Pipeline (1155)
Policy (138)
Postmarket research (2402)
Preclinical (7922)
Press Release (63)
Prostate cancer (102)
Psychedelics (37)
Radiopharmaceuticals (226)
Rare diseases (374)
Real estate (4664)
Recruiting (60)
Regulatory (19765)
Reports (25)
Research institute (2472)
Resumes & cover letters (361)
Rett syndrome (5)
RNA editing (5)
RSV (40)
Schizophrenia (74)
Series A (121)
Series B (76)
Service/supplier (5)
Sickle cell disease (55)
Special edition (10)
Spinal muscular atrophy (149)
Sponsored (29)
Startups (3041)
State (2)
Stomach cancer (14)
Supply chain (67)
Tariffs (31)
The Weekly (37)
Vaccines (678)
Venture capitalists (34)
Weight loss (233)
Women's health (28)
Worklife (18)
Date
Today (137)
Last 7 days (762)
Last 30 days (2359)
Last 365 days (29445)
2025 (9521)
2024 (31574)
2023 (35480)
2022 (46015)
2021 (49690)
2020 (48540)
2019 (42362)
2018 (32025)
2017 (28506)
2016 (27339)
2015 (31864)
2014 (24145)
2013 (20011)
2012 (21466)
2011 (22313)
2010 (19896)
Location
Africa (783)
Alabama (51)
Alaska (4)
Arizona (159)
Arkansas (11)
Asia (35719)
Australia (7411)
California (5152)
Canada (1852)
China (480)
Colorado (230)
Connecticut (220)
Delaware (136)
Europe (80910)
Florida (818)
Georgia (174)
Idaho (52)
Illinois (492)
India (25)
Indiana (287)
Iowa (7)
Japan (157)
Kansas (94)
Kentucky (21)
Louisiana (8)
Maine (55)
Maryland (808)
Massachusetts (3725)
Michigan (196)
Minnesota (309)
Mississippi (1)
Missouri (78)
Montana (24)
Nebraska (22)
Nevada (57)
New Hampshire (66)
New Jersey (1551)
New Mexico (23)
New York (1539)
North Carolina (829)
North Dakota (5)
Northern California (2233)
Ohio (175)
Oklahoma (9)
Oregon (27)
Pennsylvania (1190)
Puerto Rico (12)
Rhode Island (28)
South America (1060)
South Carolina (20)
South Dakota (1)
Southern California (1987)
Tennessee (88)
Texas (795)
United States (19801)
Utah (171)
Virginia (135)
Washington D.C. (58)
Washington State (484)
West Virginia (3)
Wisconsin (45)
580,258 Results for "wellcome trust sanger institute formerly known as sanger centre".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Building Patient Trust Amid an Environment of Distrust
While at SCOPE 2025, Sam Srivastava, CEO at WCG Clinical discusses the challenges and responsibilities of the life sciences industry in building public trust amidst growing anger towards healthcare.
February 28, 2025
·
1 min read
·
Lori Ellis
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Genetown
Wellcome Sanger Institute Adopts Genestack’s Omics Data Manager for Human Genetics Datasets
Genestack Ltd. announced that its flagship multi-omics data catalog, curation and integrative search product, Omics Data Manager, has been licensed and implemented by a world-leading genomics research centre, the Wellcome Sanger Institute.
April 22, 2021
·
3 min read
Press Releases
Advancing Scientific Trust: Oxcryo Teams Up With Bioz
April 8, 2025
·
2 min read
Press Releases
Oxford-Harrington Rare Disease Centre Appoints Majid Jafar to its Advisory Council
April 30, 2025
·
7 min read
Sanger Sequencing Services Market Trend | Increasing Application of Sanger Sequencing in Molecular Biology Techniques and Rising Funding to Accelerate Genomics and Molecular Biology Research Activities
The Sanger Sequencing Services Market is expected to grow at a CAGR of 6.5% during the forecast period , according to latest analysis by Emergen Research.
September 13, 2022
·
6 min read
Press Releases
Telo Genomics Announces Expanded Partnership with Trusted Health Advisors
February 27, 2025
·
7 min read
Press Releases
Adragos Pharma Expands in Japan: Strengthening Production, Quality, and Trust
April 8, 2025
·
1 min read
Bio NC
Atrium Health’s Sanger Heart & Vascular Institute First in the World to use Implantable Fish-Skin Grafting in Reconstructive Surgery
Atrium Health’s Sanger Heart & Vascular Institute has received a Center of Excellence designation from Kerecis®, the company pioneering the use of fish skin and fatty acids in cellular therapy, tissue regeneration and protection.
July 6, 2022
·
5 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
1 of 58,026
Next
